RE: Heard about EpiPen CEO?
August 25, 2016 at 1:57 am
(This post was last modified: August 25, 2016 at 4:34 am by Athene.)
(August 25, 2016 at 1:24 am)Cthulhu Dreaming Wrote: Patented, WTF? The delivery system appears to be a derivative of the atropine auto-injectors the military issued us in 1987 for treating exposure to nerve agent.
I don't know what's going on with the patent.
Looked on the PDL's to look into coverage of the alternatives. It appeared that Tier 1 coverage usually included Epi Pen and a recalled injector (Auvi-Q). I did see Adrenaclick covered a few times, but only under Tier 3 (non-preferred). That means at least 75 bucks a pop, if not more.
Doesn't really seem like there'd be a good reason for that unless something underhanded was taking place.
Hopefully, it'll be addressed with all the attention being brought to it.
